InflaRx (IFRX) Shares Outstanding (Diluted Average) (2016 - 2026)

InflaRx has disclosed Shares Outstanding (Diluted Average) across 11 years of filings, most recently posting $84.6 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $84.6 million, up 27.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.6 million (up 27.09% YoY), and the FY2025 annual result was $78.3 million, up 24.4% from the prior year.
• Shares Outstanding (Diluted Average) came in at $84.6 million for Q1 2026 at InflaRx, up from $78.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $84.6 million in Q1 2026 to a low of $396.19 in Q2 2025.
• The 5-year median for Shares Outstanding (Diluted Average) is $62.1 million (2023), against an average of $54.1 million.
• Across the five-year window, Shares Outstanding (Diluted Average) surged 43.82% in 2023 and tumbled 100.0% in 2024, its largest moves.
• InflaRx's Shares Outstanding (Diluted Average) stood at $45.1 million in 2022, then jumped by 31.06% to $59.1 million in 2023, then advanced by 6.51% to $63.0 million in 2024, then advanced by 24.4% to $78.3 million in 2025, then climbed by 8.06% to $84.6 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $84.6 million (Q1 2026), $78.3 million (Q4 2025), and $79.2 million (Q3 2025), per Business Quant data.